cladribine has been researched along with Diffuse Lymphocytic Lymphoma, Poorly-Differentiated in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 6 (40.00) | 29.6817 |
| 2010's | 7 (46.67) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Aladjem, MI; Epner, EM; Evans, J; Fox, T; Fu, H; Hasanali, ZS; Kester, M; LeBlanc, FR; Leshchenko, VV; Liao, J; Loughran, TP; Martin, MM; Parekh, S; Pu, JJ; Sharma, K; Shimko, S; Spurgeon, SE; Stuart, A; Zhang, Y | 1 |
| Dunleavy, K | 1 |
| Hernandez, F; Jaksa, R; Klanova, M; Klener, P; Kulvait, V; Lateckova, L; Lorkova, L; Maswabi, B; Mavis, C; Molinsky, J; Petrak, J; Pospisilova, J; Trneny, M; Vejmelkova, D; Vit, O; Vockova, P; Vokurka, M | 1 |
| Drake, MT; Fishkin, PA; Inwards, DJ; Kurtin, PJ; Lair, BS; LaPlant, BR; Nikcevich, DA; Wender, DB; Witzig, TE | 1 |
| Fujita, Y; Fukushima, T; Iwao, H; Kawanami, T; Kishi, S; Masaki, Y; Miki, M; Miyazono, T; Murakami, J; Nakajima, A; Nakamura, T; Okazaki, T; Otsuki, N; Sakai, T; Sakamaki, I; Satoh, T; Tanaka, M; Ueda, T; Urasaki, Y | 1 |
| Miller, HJ; Saven, A; Schram, ED; Sigal, DS | 1 |
| Abbi, K; Chen, Y; Chen, Z; Epner, EM; Mater, E; Okada, C; Pindyck, T; Spurgeon, SE | 1 |
| Chen, D; Colgan, JP; Hanson, CA; Ketterling, RP; Viswanatha, DS; Zent, CS | 1 |
| Bergmann, L; Burkhard, O; Chow, KU; Hansmann, ML; Hoelzer, D; Jäger, E; Karakas, T; Mezger, J; Mitrou, PS; Ritzel, H; Rummel, MJ; Schalk, KP; von Grünhagen, U | 1 |
| Blonski, JZ; Cebula, B; Chojnowski, K; Robak, T; Smolewski, P; Szmigielska-Kaplon, A | 1 |
| Ajioka, Y; Endo, T; Hasegawa, K; Homma, N; Kanefuji, T; Ogata, N; Saito, H; Shibasaki, K; Soga, K; Watanabe, T | 1 |
| Epner, E; Yu, M | 1 |
| Ansell, SM; Brown, DW; Fishkin, PA; Fonseca, R; Hillman, DW; Inwards, DJ; Kurtin, PJ; Morton, RF; Veeder, MH; Witzig, TE | 1 |
| Bergmann, L; Chow, KU; Hansmann, ML; Hoelzer, D; Hossfeld, DK; Jäger, E; Leimer, L; Meyer, A; Mitrou, PS; Peters, HD; Rummel, MJ | 1 |
| Cotelingam, JD; Glass, J; Nordberg, ML; Sattar, T; Veillon, DM | 1 |
2 review(s) available for cladribine and Diffuse Lymphocytic Lymphoma, Poorly-Differentiated
| Article | Year |
|---|---|
Beyond hairy cell: the activity of cladribine in other hematologic malignancies.
Topics: Antineoplastic Agents; Cladribine; Hematologic Neoplasms; Humans; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Waldenstrom Macroglobulinemia | 2010 |
The epigenetics of mantle cell lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cyclophosphamide; Dexamethasone; DNA Methylation; Doxorubicin; Epigenesis, Genetic; Humans; Lymphoma, Mantle-Cell; Prednisone; Rituximab; Vincristine | 2007 |
6 trial(s) available for cladribine and Diffuse Lymphocytic Lymphoma, Poorly-Differentiated
| Article | Year |
|---|---|
Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphoma.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Disease-Free Survival; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Lymphoma, Mantle-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Rituximab; Sirolimus | 2014 |
Prospective clinical study of R-CMD therapy for indolent B cell lymphoma and mantle cell lymphoma from the Hokuriku Hematology Oncology Study Group.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Dexamethasone; Female; Humans; Lymphoma, B-Cell; Lymphoma, Mantle-Cell; Male; Middle Aged; Mitoxantrone; Prospective Studies; Rituximab | 2015 |
Reduced-dose cladribine (2-CdA) plus mitoxantrone is effective in the treatment of mantle-cell and low-grade non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Disease-Free Survival; Female; Humans; Infusions, Intravenous; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prospective Studies; Treatment Outcome | 2002 |
Rituximab combined with cladribine or with cladribine and cyclophosphamide in heavily pretreated patients with indolent lymphoproliferative disorders and mantle cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cyclophosphamide; Drug Resistance, Neoplasm; Female; Humans; Lymphoma, Mantle-Cell; Lymphoproliferative Disorders; Male; Middle Aged; Rituximab; Treatment Outcome | 2006 |
Long-term results of the treatment of patients with mantle cell lymphoma with cladribine (2-CDA) alone (95-80-53) or 2-CDA and rituximab (N0189) in the North Central Cancer Treatment Group.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Lymphoma, Mantle-Cell; Male; Middle Aged; Rituximab; Survival Analysis | 2008 |
Intermittent 2-hour-infusion of cladribine as first-line therapy or in first relapse of progressive advanced low-grade and mantle cell lymphomas.
Topics: Adult; Aged; Antineoplastic Agents; Cladribine; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Germany; Humans; Infusions, Intravenous; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Middle Aged; Recurrence; Remission Induction; Treatment Outcome | 1999 |
7 other study(ies) available for cladribine and Diffuse Lymphocytic Lymphoma, Poorly-Differentiated
| Article | Year |
|---|---|
Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma.
Topics: Adult; Antigens, CD20; Cladribine; Epigenesis, Genetic; Humans; Immunologic Factors; Immunotherapy; Lymphoma, Mantle-Cell; Neoplasm Recurrence, Local; Rituximab; Vorinostat | 2022 |
Epigenetic targeting in mantle cell lymphoma.
Topics: Adult; B-Lymphocytes; Cladribine; Epigenesis, Genetic; Humans; Lymphoma, Mantle-Cell; Rituximab; Vorinostat | 2019 |
Downregulation of deoxycytidine kinase in cytarabine-resistant mantle cell lymphoma cells confers cross-resistance to nucleoside analogs gemcitabine, fludarabine and cladribine, but not to other classes of anti-lymphoma agents.
Topics: Animals; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; Cladribine; Clone Cells; Cytarabine; Deoxycytidine; Deoxycytidine Kinase; Down-Regulation; Drug Resistance, Neoplasm; Electrophoresis, Gel, Two-Dimensional; Gemcitabine; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, Mantle-Cell; Mass Spectrometry; Mice; Proteomics; Rituximab; Vidarabine; Xenograft Model Antitumor Assays | 2014 |
Cladribine plus rituximab is an effective therapy for newly diagnosed mantle cell lymphoma.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymphoma, Mantle-Cell; Male; Middle Aged; Prognosis; Remission Induction; Retrospective Studies; Rituximab; Time Factors; Treatment Outcome | 2011 |
A case of hairy cell leukemia with CCND1-IGH@ translocation: indolent non-nodal mantle cell lymphoma revisited.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cyclin D1; Cyclophosphamide; Doxorubicin; Drug Substitution; Humans; Immunoglobulin Heavy Chains; Leukemia, Hairy Cell; Lymphoma, Mantle-Cell; Male; Middle Aged; Prednisone; Remission Induction; Translocation, Genetic; Treatment Failure; Vincristine; Withholding Treatment | 2011 |
Complete response in a patient with colonic mantle cell lymphoma with multiple lymphomatous polyposis treated with combination chemotherapy using anti-CD20 antibody and cladribine.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Colonic Neoplasms; Female; Humans; Lymphoma, Mantle-Cell; Middle Aged; Rituximab | 2007 |
Prolymphocytic leukemia or prolymphocytic transformation of mantle cell lymphoma.
Topics: Antigens, CD; Biomarkers, Tumor; Bone Marrow; Cell Transformation, Neoplastic; Cladribine; DNA, Neoplasm; Humans; Immunophenotyping; In Situ Hybridization, Fluorescence; Leukemia, B-Cell; Leukemia, Prolymphocytic; Lymphoma, Mantle-Cell; Male; Middle Aged | 2001 |